Aristotle Capital Boston LLC Sells 43,922 Shares of Pediatrix Medical Group, Inc. $MD

Aristotle Capital Boston LLC lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 9.1% in the 4th quarter, Holdings Channel reports. The firm owned 440,063 shares of the company’s stock after selling 43,922 shares during the period. Aristotle Capital Boston LLC’s holdings in Pediatrix Medical Group were worth $9,413,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Bridgeway Capital Management LLC boosted its holdings in shares of Pediatrix Medical Group by 14.5% during the 4th quarter. Bridgeway Capital Management LLC now owns 740,280 shares of the company’s stock valued at $15,835,000 after purchasing an additional 93,488 shares during the last quarter. Guggenheim Capital LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter valued at about $747,000. AQR Capital Management LLC boosted its holdings in shares of Pediatrix Medical Group by 4.7% during the 4th quarter. AQR Capital Management LLC now owns 551,823 shares of the company’s stock valued at $11,803,000 after purchasing an additional 24,633 shares during the last quarter. Cetera Investment Advisers boosted its holdings in shares of Pediatrix Medical Group by 48.4% during the 4th quarter. Cetera Investment Advisers now owns 16,808 shares of the company’s stock valued at $360,000 after purchasing an additional 5,481 shares during the last quarter. Finally, Lazard Asset Management LLC boosted its holdings in shares of Pediatrix Medical Group by 34.3% during the 4th quarter. Lazard Asset Management LLC now owns 138,358 shares of the company’s stock valued at $2,959,000 after purchasing an additional 35,349 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on MD shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. UBS Group increased their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Truist Financial increased their price target on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a report on Monday, April 13th. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a report on Friday, May 8th. Finally, Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a report on Friday, February 20th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $22.50.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock opened at $23.56 on Thursday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. Pediatrix Medical Group, Inc. has a 1-year low of $11.84 and a 1-year high of $24.99. The firm has a market capitalization of $1.93 billion, a P/E ratio of 11.44 and a beta of 0.69. The company’s 50-day moving average is $22.58 and its 200 day moving average is $21.70.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million for the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share. Research analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current year.

Insider Activity at Pediatrix Medical Group

In other news, Director Shirley A. Weis sold 36,028 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.80% of the company’s stock.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.